Blog
Real-World Analysis Evaluates Inpatient Vs Outpatient CAR T-Cell Therapy Administration in MCL and F
As CAR T-cell therapies have gained approvals in relapsed/refractory mantle
April 20, 2023
As CAR T-cell therapies have gained approvals in relapsed/refractory mantle
One of the challenges of CAR T cell therapy in
The accumulation of fat in the liver is an increasingly
Multiple myeloma is difficult to treat because of the heterogeneity
Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy that
Many ovarian tumors contain mesothelin. Researchers wanted to test three
CAR T cells have shown some success in the clinic
T-cell transfer therapies have not yet been successfully applied to
Lymphomas can begin in the brain or spinal cord, or
